FDA approves first gene-editing therapy
The Food and Drug Administration (FDA) recently approved Casgevy (exagamglogene autotemcel), the first cell-based gene-editing therapy to utilise the CRISPR/Cas9 system (CRISPR) in history, to treat transfusion-dependent...
